title: Cilioretinal artery and central retinal vein occlusion after sildenafil use.
authors: Faculty of Medicine, Department A of Ophthalmology, Mohammed V University Souissi, Teaching Hospital of Rabat, Rabat, Morocco.
authors: Zouheir
authors: Z
authors: Hafidi
authors: Faculty of Medicine, Department A of Ophthalmology, Mohammed V University Souissi, Teaching Hospital of Rabat, Rabat, Morocco.
authors: Hanan
authors: H
authors: Handor
authors: Faculty of Medicine, Department A of Ophthalmology, Mohammed V University Souissi, Teaching Hospital of Rabat, Rabat, Morocco.
authors: Mina
authors: M
authors: Laghmari
authors: Faculty of Medicine, Department A of Ophthalmology, Mohammed V University Souissi, Teaching Hospital of Rabat, Rabat, Morocco.
authors: Rajae
authors: R
authors: Daoudi
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000068258:Bevacizumab / Q000627:therapeutic use; D019842:Ciliary Arteries / Q000187:drug effects*; D005451:Fluorescein Angiography; D006801:Humans; D008028:Light Coagulation; D008297:Male; D015356:Retinal Artery Occlusion / Q000139:chemically induced* / Q000628:therapy; D012170:Retinal Vein Occlusion / Q000139:chemically induced* / Q000628:therapy; D000068677:Sildenafil Citrate / Q000009:adverse effects*; D041623:Tomography, Optical Coherence; D014665:Vasodilator Agents / Q000009:adverse effects*; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D014665:Vasodilator Agents; D000068258:Bevacizumab; D000068677:Sildenafil Citrate
keywords: Ophthalmology